Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis - PubMed (original) (raw)
Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis
X Chevalier et al. Arthritis Rheum. 1994 Jul.
Abstract
Objective: To determine whether tenascin is present in normal and diseased human cartilage.
Methods: Immunohistochemical and biochemical assays with a monoclonal antibody against all tenascin isoforms (BC-4) were used.
Results: Cartilage samples from osteoarthritis and rheumatoid arthritis patients contained increased amounts of tenascin compared with the levels in normal cartilage. Human fetal cartilage was also found to contain tenascin. In normal cartilage explants treated with interleukin-1 beta, tenascin was present in pericellular areas of all layers. Immunolocalization studies revealed that tenascin was most abundant in the superficial layers of osteoarthritic cartilage. Western blot analysis performed from dissociative extracts of diseased cartilage confirmed the presence of subunits of the native molecule.
Conclusion: Tenascin is increased in arthritic cartilage and is weakly expressed in normal cartilage.
Similar articles
- Tenascin and arthritis.
Cutolo M. Cutolo M. Br J Rheumatol. 1994 Feb;33(2):197-8. doi: 10.1093/rheumatology/33.2.197. Br J Rheumatol. 1994. PMID: 7512882 No abstract available. - Influence of interleukin 1 beta on tenascin distribution in human normal and osteoarthritic cartilage: a quantitative immunohistochemical study.
Chevalier X, Claudepierre P, Groult N, Godeau GJ. Chevalier X, et al. Ann Rheum Dis. 1996 Oct;55(10):772-5. doi: 10.1136/ard.55.10.772. Ann Rheum Dis. 1996. PMID: 8984945 Free PMC article. - Tenascin is increased in cartilage and synovium from arthritic knees.
Salter DM. Salter DM. Br J Rheumatol. 1993 Sep;32(9):780-6. doi: 10.1093/rheumatology/32.9.780. Br J Rheumatol. 1993. PMID: 7690296 - Role of tenascin-C in articular cartilage.
Hasegawa M, Yoshida T, Sudo A. Hasegawa M, et al. Mod Rheumatol. 2018 Mar;28(2):215-220. doi: 10.1080/14397595.2017.1349560. Epub 2017 Jul 19. Mod Rheumatol. 2018. PMID: 28722504 Review. - The role of type IX collagen in osteoarthritis and rheumatoid arthritis.
Diab M. Diab M. Orthop Rev. 1993 Feb;22(2):165-70. Orthop Rev. 1993. PMID: 8451069 Review.
Cited by
- Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage.
Patel L, Sun W, Glasson SS, Morris EA, Flannery CR, Chockalingam PS. Patel L, et al. BMC Musculoskelet Disord. 2011 Jul 15;12:164. doi: 10.1186/1471-2474-12-164. BMC Musculoskelet Disord. 2011. PMID: 21762512 Free PMC article. - Tenascin-C in Osteoarthritis and Rheumatoid Arthritis.
Hasegawa M, Yoshida T, Sudo A. Hasegawa M, et al. Front Immunol. 2020 Sep 30;11:577015. doi: 10.3389/fimmu.2020.577015. eCollection 2020. Front Immunol. 2020. PMID: 33101302 Free PMC article. Review. - Overview of distinct N6-Methyladenosine profiles of messenger RNA in osteoarthritis.
Yu Y, Lu S, Li Y, Xu J. Yu Y, et al. Front Genet. 2023 May 9;14:1168365. doi: 10.3389/fgene.2023.1168365. eCollection 2023. Front Genet. 2023. PMID: 37229206 Free PMC article. - Articular cartilage calcification and matrix vesicles.
Howell DS. Howell DS. Curr Rheumatol Rep. 2002 Jun;4(3):265-9. doi: 10.1007/s11926-002-0075-0. Curr Rheumatol Rep. 2002. PMID: 12010613 Review. - Immunopathogenesis of osteoarthritis.
Haseeb A, Haqqi TM. Haseeb A, et al. Clin Immunol. 2013 Mar;146(3):185-96. doi: 10.1016/j.clim.2012.12.011. Epub 2013 Jan 6. Clin Immunol. 2013. PMID: 23360836 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical